Health | Science | Technology | Space | Sports | Entertainment | Mobile | Games | Economy | Politics | Movies | Music | [Top News]

Posts tagged: treating

A new candidate pathway for treating visceral obesity

May 6, 2012
BOSTON, MABrown seems to be the color of choice when it comes to the types of fat cells in our bodies. Brown fat expends energy, while its counterpart, white fat stores it. The danger in white fat cells, along with the increased risk for diabetes and heart disease it poses, ...

A new candidate pathway for treating visceral obesity

May 6, 2012
(Brigham and Women's Hospital) Brown seems to be the color of choice when it comes to the types of fat cells in our bodies. Brown fat expends energy, while its counterpart, white fat stores it. Now a team of researchers led by Jorge Plutzky, M.D., of Brigham and Women's Hospital ...

Human stem cells effective in treating muscular dystrophy

May 5, 2012
Researchers from the University of Minnesota's Lillehei Heart Institute have effectively treated muscular dystrophy in mice using human stem cells derived from a new process that - for the first time - makes the production of human muscle cells from stem cells efficient and effective.

Novel Method For Treating Sepsis

May 4, 2012
Margination, the natural phenomenon where bacteria and leukocytes (white blood cells) move toward the sides of blood vessels, is the inspiration for a novel method for treating sepsis, a systemic and often dangerous inflammatory response to microbial infection in the blood...

Triple Combination Therapy Proves Effective For Treating Hypertension

May 2, 2012
Results from two studies were presented at the 22nd European Society of Hypertension (ESH) in London highlighting the benefits of triple combination therapy for individuals suffering from hypertension. The results add to clinical understanding of olmesartan(O)/amlodipine(A)/hydrochlorothiazide(H) (O/A/H) triple combination therapy (Sevikar HCT®). About 15 to 20% ...

Comparison Of Avastin And Lucentis In Treating Age-Related Macular Degeneration

May 2, 2012
At two years, Avastin (bevacizumab) and Lucentis (ranibizumab injection), two widely used drugs to treat age-related macular degeneration (AMD), improve vision when administered monthly or on an as needed basis, although greater improvements in vision were seen with monthly administration for this common, debilitating eye disease, according to researchers supported ...

Health, prognosis not taken into account when treating older lung cancer patients, study finds

May 2, 2012
(University of California - San Francisco) In a study of patients 65 and older with non-small-cell lung cancer, younger patients were more likely to receive treatment than older patients, regardless of overall health and prognosis.

Treating childhood obesity: A family affair

May 1, 2012
WINSTON-SALEM, N.C. May 1, 2012 With nearly one-third of American children being overweight or obese, doctors agree that there is an acute need for more effective treatments. In many weight management programs, the dropout rate can be as high as 73 percent, and even in successful programs, the ...

Treating Traumatic Shoulder Injuries: New Standards To Improve Patient Care

May 1, 2012
Traumatic shoulder injuries that result in a patient visit to the ER often contain a secondary injury that can cause pain and discomfort in that part of the body after the primary injury has healed. By focusing on the primary injury, radiologists sometimes miss the secondary injury, which can compromise ...

Treating childhood obesity: A family affair

May 1, 2012
(Wake Forest Baptist Medical Center) With nearly one-third of American children being overweight or obese, doctors agree that there is an acute need for more effective treatments. In many weight management programs, the dropout rate can be as high as 73 percent, and even in successful programs, the benefits are ...

Avastin and Lucentis are equivalent in treating age-related macular degeneration

April 30, 2012
(NIH/National Eye Institute) At two years, Avastin (bevacizumab) and Lucentis (ranibizumab injection), two widely used drugs to treat age-related macular degeneration (AMD), improve vision when administered monthly or on an as needed basis, although greater improvements in vision were seen with monthly administration for this common, debilitating eye disease, ...

Cleveland Clinic-led study finds Lucentis and Avastin equivalent in treating AMD

April 30, 2012
(Cleveland Clinic) In a landmark drug-comparison study, Cleveland Clinic researchers found that bevacizumab (Avastin) is equivalent to ranibizumab (Lucentis) in the treatment of wet age-related macular degeneration (AMD) through two years.